An 18-year-old Italian lady has died from a uncommon type of blood clot two weeks after receiving the AstraZeneca jab in Northern Italy, and a 34-year-old girl, from the identical area, is in a coma.

Native media reported the preliminary investigation into {the teenager}’s dying confirmed she suffered from low blood platelets, a situation the European Medical Company has linked to uncommon blood clots together with the AstraZeneca vaccine. 

It’s unknown whether or not she declared her situation earlier than she obtained the vaccine at an “open day” final month.

Giovanni Toti, the regional governor of Liguria, stated final week that Aifa, the nationwide pharma regulator, was investigating a direct reference to the jabs.

On Friday night, Italian officers stated AstraZeneca vaccines will probably be banned beneath 60 years of age and over 1m individuals below 60, who have been awaiting their second dose, will probably be inoculated with mRNA vaccines similar to BioNTech/Pfizer and Moderna as an alternative. The pinnacle of the federal government’s Covid taskforce, Franco Locatelli, instructed a press convention it was affordable to imagine mixing the vaccines wouldn’t be detrimental, quite the opposite it could be “advantageous” when it comes to effectiveness. 

Italy’s regional governments have been selling vaccinations for younger individuals for the reason that finish of Could of their efforts to spice up whole immunisations and encourage summer time tourism as the educational yr attracts to an finish.

Whereas Aifa stated in April AstraZeneca ought to “preferentially” be administered to individuals aged 60 and above, many older individuals shunned the vaccine and the areas used tens of 1000’s of leftover doses on youthful individuals.

Immunologist Antonella Viola stated “providing AstraZeneca to younger individuals had been a mistake”.

Nino Cartabellotta, of the scientific think-tank Gimbe, stated on Thursday the information accessible prompt mRNA vaccines, like Pfizer and Moderna, ought to be reserved for individuals beneath 50 years of age whereas AstraZeneca and Johnson & Johnson ought to go to older individuals.

Nevertheless, regional authorities stated they’d obtained no clear indication from the nationwide authorities.

In northern areas, similar to Lombardy, Veneto, Emilia Romagna and Liguria, bookings have been open to adolescents from the age of 12 since final week.

Open days, when 1000’s of younger individuals have been inoculated with out pre-booking their jab, have drawn widespread criticism from politicians and consultants who warned there was a scarcity of information on the consequences of the vaccines on adolescents. Others stated vaccines shouldn’t be wasted on individuals belonging to low-risk age teams.

A complete of 40.5m vaccines have been administered in Italy with 25 per cent of the Italian inhabitants totally immunised.

Authorities figures present that 283,000 doses have gone to individuals aged 12-19.

Well being minister Roberto Speranza stated the federal government was awaiting enter from its advisers earlier than making a last determination on banning AstraZeneca for sure age teams.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *